What is it about?
Medical ghostwriting facilitated misrepresentation of the study outcomes.
Featured Image
Why is it important?
Pharmaceutical industry-sponsored clinical trials are notorious for scientific misconduct
Read the Original
This page is a summary of: The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance, International Journal of Risk & Safety in Medicine, March 2016, IOS Press,
DOI: 10.3233/jrs-160671.
You can read the full text:
Contributors
The following have contributed to this page
